Skip to content

Clinical trials

Terminated Leukemia, Lymphocytic, Chronic, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Terminated Country / region: China Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines1
MingSight Pharmaceuticals, Inc1
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.1
The First Affiliated Hospital with Nanjing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Mantle-Cell2
Leukemia, Lymphoid1
Lymphoma, B-Cell1
Lymphoma, Non-Hodgkin1
Recurrence1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.